(Q49015332)

17 February 2018

title

Neuropeptide regulation of cell-mediated cytotoxicity against human tumor cells (English)

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

2 November 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

2 November 2022

author name string

E. A. Van Tol

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701225

2 November 2022

H. W. Verspaget

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701225

2 November 2022

C. B. Lamers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701225

2 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1701225

2 November 2022

publication date

1 May 1990

1 reference

17 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:014341799090026U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

https://api.elsevier.com/content/article/PII:014341799090026U?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

2 November 2022

1 reference

17 February 2018

volume

16

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

25-32

1 reference

17 February 2018

cites work

Neuroimmunology.

1

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Neuropeptides and other mediators in the central nervous system

2 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Immune-neuroendocrine interactions

2 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Neurohormonal regulation of gastrointestinal immunity

2 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Neuropeptides and gastrointestinal immunity.

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Gastrointestinal regulatory peptides modulate mouse lymphocyte functions under serum-free conditions in vitro

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Specific stimulation of human T lymphocytes by substance P

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Mast cell heterogeneity: effects of neuroenteric peptides on histamine release

2 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Effect of neuropeptides on production of inflammatory cytokines by human monocytes

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Neuropeptides modulating macrophage function

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

The effects of vasoactive intestinal peptide on human natural killer cell function

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Vaso-active intestinal peptide: a neurotransmitter which reduces human NK cell activity and increases Ig synthesis

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Enhancement of human lymphocyte natural killer activity by somatostatin

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Neuroendocrine potential of the colon and rectum.

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Somatostatin (second of two parts).

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity

2 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0143-4179(90)90026-U

2 November 2022

Identifiers

1 reference

17 February 2018

1 reference

17 February 2018